Scarica l'app Stockscreener
117.36
1.26%
1.46
Dopo l'orario di chiusura:
117.42
0.06
+0.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$115.90
Aprire:
$115.575
Volume 24 ore:
4.82M
Relative Volume:
1.07
Capitalizzazione di mercato:
$202.64B
Reddito:
$41.22B
Utile/perdita netta:
$5.77B
Rapporto P/E:
39.92
EPS:
2.94
Flusso di cassa netto:
$6.49B
1 W Prestazione:
+0.48%
1M Prestazione:
-1.70%
6M Prestazione:
+12.75%
1 anno Prestazione:
+17.89%
Intervallo 1D:
$115.51
$117.94
Intervallo di 1 settimana:
$114.43
$117.94
Portata 52W:
$98.95
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Nome
Abbott Laboratories
Settore
Industria
Telefono
(224) 667-6100
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Confronta ABT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-08 | Iniziato | Oppenheimer | Outperform |
| 2024-09-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Downgrade | Edward Jones | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-21 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Reiterato | Barclays | Overweight |
| 2023-04-20 | Reiterato | Bernstein | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Raymond James | Outperform |
| 2023-04-20 | Reiterato | UBS | Buy |
| 2023-04-20 | Reiterato | Wolfe Research | Underperform |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-27 | Reiterato | Credit Suisse | Outperform |
| 2022-01-27 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-01-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-06-01 | Downgrade | Goldman | Neutral → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-02-07 | Reiterato | BofA/Merrill | Buy |
| 2019-01-02 | Downgrade | Citigroup | Neutral → Sell |
| 2018-11-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-01-30 | Reiterato | Citigroup | Neutral |
| 2018-01-25 | Reiterato | Stifel | Buy |
| 2018-01-25 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-19 | Reiterato | Stifel | Buy |
Mostra tutto
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott opens new Kilkenny site for diabetes tech - SiliconRepublic.com
Mawer Investment Management Ltd. Sells 24,407 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Opens New Diabetes Care Mfg Facility in Ireland - MPO-mag
First Western Trust Bank Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott opens new FreeStyle Libre manufacturing plant in Ireland - Mass Device
MAI Capital Management Sells 9,904 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
US medtech firm Abbott creates 800 jobs in Kilkenny - Irish Independent
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland - cnhinews.com
Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology - Benzinga
Swiss National Bank Purchases 26,000 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
With 77% institutional ownership, Abbott Laboratories (NYSE:ABT) is a favorite amongst the big guns - Simply Wall St
Mizuho Securities USA LLC Has $12.86 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Mutual of America Capital Management LLC Has $24.39 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Mizuho Markets Americas LLC - MarketBeat
Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now - Insider Monkey
Natixis Advisors LLC Purchases 204,478 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Sells 4,596 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Has $13.82 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ipswich Investment Management Co. Inc. Cuts Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Miramar Capital LLC - MarketBeat
Abbott extends executive agreements through 2026 By Investing.com - Investing.com Nigeria
Abbott Laboratories (ABT) Extends Executive Change in Control Ag - GuruFocus.com
Abbott Inks $8M Deal With Healthcare Fraudster In TM Suit - Law360
Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Abbott Laboratories (NYSE:ABT) Stock Position Increased by First Long Island Investors LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Simplify Asset Management Inc. - MarketBeat
Vectors Research Management LLC Makes New Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Raised by CIBC Asset Management Inc - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Dearborn Partners LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Curi RMB Capital LLC - MarketBeat
Victory Capital Management Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Entropy Technologies LP Has $611,000 Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Drug Device Combination Market Is Booming Worldwide | 3M, Abbott Laboratories, AlloSource, Biomet Orthopedics Inc - openPR
Judge Finds Dexcom Infringed Abbott Patent That Hung Jury - Law360
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
Abbott Gets Damages Trial as Judge Adds to DexCom's Patent Woes - Bloomberg Law
Topics: Missouri Margo Gill v. Abbott Laboratories, et al. - CVN News
ING Groep NV Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Sivik Global Healthcare LLC Takes $6.84 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Ferguson Wellman Capital Management Inc. - MarketBeat
Abbott Laboratories (NYSE:ABT) Stake Raised by KBC Group NV - MarketBeat
Versor Investments LP Acquires New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Los Angeles Capital Management LLC Sells 54,709 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Labs granted variances for fencing and buffer areas for new plant on north end of BG - BG Independent News
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott Laboratories (NYSE:ABT) Shares Acquired by Schrum Private Wealth Management LLC - MarketBeat
Oppenheimer Asset Management Inc. Has $28.78 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Saturna Capital Corp Cuts Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Position Raised by Dillon & Associates Inc. - MarketBeat
Prime Capital Investment Advisors LLC Sells 26,308 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Labor - GuruFocus.com
Abbott Laboratories Azioni (ABT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):